SI3775909T1 - Sredstva in postopki za glikoprofiliranje proteina - Google Patents
Sredstva in postopki za glikoprofiliranje proteinaInfo
- Publication number
- SI3775909T1 SI3775909T1 SI201930572T SI201930572T SI3775909T1 SI 3775909 T1 SI3775909 T1 SI 3775909T1 SI 201930572 T SI201930572 T SI 201930572T SI 201930572 T SI201930572 T SI 201930572T SI 3775909 T1 SI3775909 T1 SI 3775909T1
- Authority
- SI
- Slovenia
- Prior art keywords
- glycoprofiling
- protein
- methods
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
- G01N2333/42—Lectins, e.g. concanavalin, phytohaemagglutinin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4724—Lectins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
- G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7095—Inflammation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18163899 | 2018-03-26 | ||
| EP19718572.1A EP3775909B1 (en) | 2018-03-26 | 2019-03-25 | Means and methods for glycoprofiling of a protein |
| PCT/EP2019/057386 WO2019185515A1 (en) | 2018-03-26 | 2019-03-25 | Means and methods for glycoprofiling of a protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3775909T1 true SI3775909T1 (sl) | 2023-10-30 |
Family
ID=61800357
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201930572T SI3775909T1 (sl) | 2018-03-26 | 2019-03-25 | Sredstva in postopki za glikoprofiliranje proteina |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20210048437A1 (sl) |
| EP (2) | EP4253958A3 (sl) |
| JP (1) | JP2021519443A (sl) |
| KR (1) | KR102711673B1 (sl) |
| AU (1) | AU2019246007A1 (sl) |
| CA (1) | CA3091733A1 (sl) |
| DK (1) | DK3775909T3 (sl) |
| ES (1) | ES2950740T3 (sl) |
| FI (1) | FI3775909T3 (sl) |
| HR (1) | HRP20230744T1 (sl) |
| HU (1) | HUE062414T2 (sl) |
| IL (1) | IL277194A (sl) |
| LT (1) | LT3775909T (sl) |
| PL (1) | PL3775909T3 (sl) |
| PT (1) | PT3775909T (sl) |
| RS (1) | RS64431B1 (sl) |
| SI (1) | SI3775909T1 (sl) |
| WO (1) | WO2019185515A1 (sl) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111208304B (zh) * | 2020-01-20 | 2023-06-16 | 中国医学科学院北京协和医院 | 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途 |
| CN113009130B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| CN113009131B (zh) * | 2021-02-10 | 2022-08-23 | 中国医学科学院北京协和医院 | 一种用于诊断原发性干燥综合征的生物标志物及其用途 |
| WO2022186317A1 (ja) * | 2021-03-03 | 2022-09-09 | 株式会社先端生命科学研究所 | がん検出方法、がん検査方法、及びこれらに用いるキット |
| AU2022323753A1 (en) | 2021-08-06 | 2024-02-29 | Glycanostics S.R.O. | Standard for glycoprofiling of proteins |
| CN113702637B (zh) * | 2021-08-09 | 2023-04-07 | 西北大学 | 乳腺癌新辅助化疗疗效预测的凝集素测试载体和试剂盒以及预测模型 |
| CN113721029B (zh) * | 2021-08-25 | 2023-06-06 | 西北大学 | 特定凝集素组合鉴别肝硬化、肝癌的测试工具及系统 |
| WO2023025927A1 (en) | 2021-08-26 | 2023-03-02 | Glycanostics S.R.O | Glycoprotein biomarkers for diagnosing cancer |
| EP4396583A1 (en) | 2021-09-14 | 2024-07-10 | Glycanostics s.r.o. | Use of lectins to determine mammaglobin-a glycoforms in breast cancer |
| WO2023198337A1 (en) | 2022-04-12 | 2023-10-19 | Glycanostics S.R.O. | Means and methods for high-throughput glycoprofiling of proteins |
| WO2024059750A2 (en) * | 2022-09-16 | 2024-03-21 | Venn Biosciences Corporation | Diagnosis of ovarian cancer using targeted quantification of site-specific protein glycosylation |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4676A (en) | 1846-07-31 | roller | ||
| US567A (en) | 1838-01-09 | Machine for r-uibbii | ||
| US980A (en) | 1838-10-13 | Improvement in the mode of hardening or chilling the hubs of car and other wheels | ||
| US4816A (en) | 1846-10-17 | Bell machinery for hotels | ||
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| JPS6147500A (ja) | 1984-08-15 | 1986-03-07 | Res Dev Corp Of Japan | キメラモノクロ−ナル抗体及びその製造法 |
| EP0173494A3 (en) | 1984-08-27 | 1987-11-25 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric receptors by dna splicing and expression |
| GB8422238D0 (en) | 1984-09-03 | 1984-10-10 | Neuberger M S | Chimeric proteins |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| JP3101690B2 (ja) | 1987-03-18 | 2000-10-23 | エス・ビィ・２・インコーポレイテッド | 変性抗体の、または変性抗体に関する改良 |
| EP0768377A1 (en) | 1988-09-02 | 1997-04-16 | Protein Engineering Corporation | Generation and selection of recombinant varied binding proteins |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
| DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| GB9021679D0 (en) | 1990-10-05 | 1990-11-21 | Gorman Scott David | Antibody preparation |
| DK0564531T3 (da) | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
| EP1279731B1 (en) | 1991-03-01 | 2007-05-30 | Dyax Corporation | Process for the development of binding mini-proteins |
| ATE269401T1 (de) | 1991-04-10 | 2004-07-15 | Scripps Research Inst | Bibliotheken heterodimerer rezeptoren mittels phagemiden |
| EP0940468A1 (en) | 1991-06-14 | 1999-09-08 | Genentech, Inc. | Humanized antibody variable domain |
| DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
| CA2761116A1 (en) | 1995-04-27 | 1996-10-31 | Amgen Fremont Inc. | Human antibodies derived from immunized xenomice |
| EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| ATE549918T1 (de) | 1996-12-03 | 2012-04-15 | Amgen Fremont Inc | Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden |
| WO1998052976A1 (en) | 1997-05-21 | 1998-11-26 | Biovation Limited | Method for the production of non-immunogenic proteins |
| DE69934967T2 (de) | 1998-12-08 | 2007-12-06 | Biovation Ltd. | Verfahren zur verminderung der immunogenität von proteinen |
| US7838634B2 (en) * | 2005-04-15 | 2010-11-23 | Van Andel Research Institute | Methods for measuring glycan levels of proteins |
| JP4711190B2 (ja) * | 2006-07-28 | 2011-06-29 | 国立大学法人 東京大学 | グリコシル化異常症の検査方法 |
| WO2009075883A2 (en) * | 2007-12-12 | 2009-06-18 | University Of Georgia Research Foundation, Inc. | Glycoprotein cancer biomarker |
| US9169327B2 (en) | 2008-03-12 | 2015-10-27 | Rowan University | Targeting of podoplanin with lectin for use in the prevention and treatment of cancer |
| WO2010011357A2 (en) * | 2008-07-25 | 2010-01-28 | The Johns Hopkins University | Detection of prostate cancer using psa glycosylation patterns |
| JP2010091308A (ja) * | 2008-10-04 | 2010-04-22 | Sapporo Medical Univ | レクチン吸収法による前立腺がんの診断方法及び判定キット |
-
2019
- 2019-03-25 SI SI201930572T patent/SI3775909T1/sl unknown
- 2019-03-25 LT LTEPPCT/EP2019/057386T patent/LT3775909T/lt unknown
- 2019-03-25 EP EP23172000.4A patent/EP4253958A3/en active Pending
- 2019-03-25 RS RS20230533A patent/RS64431B1/sr unknown
- 2019-03-25 EP EP19718572.1A patent/EP3775909B1/en active Active
- 2019-03-25 PL PL19718572.1T patent/PL3775909T3/pl unknown
- 2019-03-25 WO PCT/EP2019/057386 patent/WO2019185515A1/en unknown
- 2019-03-25 FI FIEP19718572.1T patent/FI3775909T3/fi active
- 2019-03-25 CA CA3091733A patent/CA3091733A1/en active Pending
- 2019-03-25 DK DK19718572.1T patent/DK3775909T3/da active
- 2019-03-25 KR KR1020207030659A patent/KR102711673B1/ko active IP Right Grant
- 2019-03-25 HR HRP20230744TT patent/HRP20230744T1/hr unknown
- 2019-03-25 US US17/041,816 patent/US20210048437A1/en active Pending
- 2019-03-25 PT PT197185721T patent/PT3775909T/pt unknown
- 2019-03-25 ES ES19718572T patent/ES2950740T3/es active Active
- 2019-03-25 HU HUE19718572A patent/HUE062414T2/hu unknown
- 2019-03-25 AU AU2019246007A patent/AU2019246007A1/en active Pending
- 2019-03-25 JP JP2021501084A patent/JP2021519443A/ja active Pending
-
2020
- 2020-09-07 IL IL277194A patent/IL277194A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20230744T1 (hr) | 2023-10-27 |
| LT3775909T (lt) | 2023-08-10 |
| DK3775909T3 (da) | 2023-07-24 |
| FI3775909T3 (fi) | 2023-08-01 |
| EP3775909B1 (en) | 2023-05-10 |
| EP3775909A1 (en) | 2021-02-17 |
| WO2019185515A1 (en) | 2019-10-03 |
| EP4253958A2 (en) | 2023-10-04 |
| HUE062414T2 (hu) | 2023-10-28 |
| JP2021519443A (ja) | 2021-08-10 |
| PT3775909T (pt) | 2023-07-19 |
| EP4253958A3 (en) | 2023-12-06 |
| KR20200138300A (ko) | 2020-12-09 |
| AU2019246007A1 (en) | 2020-09-10 |
| IL277194A (en) | 2020-10-29 |
| RS64431B1 (sr) | 2023-09-29 |
| ES2950740T3 (es) | 2023-10-13 |
| CA3091733A1 (en) | 2019-10-03 |
| KR102711673B1 (ko) | 2024-09-30 |
| US20210048437A1 (en) | 2021-02-18 |
| PL3775909T3 (pl) | 2023-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277194A (en) | Means and methods for glycoprofiling of protein | |
| ZA202105676B (en) | Anti-trem2 antibodies and related methods | |
| IL272218A (en) | ANTI-SIRP-ALPHA ANTIBODIES AND RELATED METHODS | |
| IL267861A (en) | PD1-41BBL conjugate protein and methods of using it | |
| ZA202003695B (en) | Anti-neuropilin antigen-binding proteins and methods of use thereof | |
| IL269074A (en) | Proteins that bind anti-TIGIT antigens and methods of using them | |
| IL267862A (en) | SIRPalpha-41BBL conjugate protein and methods of using it | |
| IL287318A (en) | Materials and methods for the production of proteins | |
| IL277212A (en) | Anti-KLK5 antibodies and methods of use | |
| SG11202012529VA (en) | Means and methods for increased protein expression by use of transcription factors | |
| DK3737402T3 (en) | Modificeret protein | |
| IL276102A (en) | System and method for characterizing protein dimerization | |
| IL279355A (en) | Antigen binding protein against STEAP1 | |
| IL291284A (en) | Systems and methods for expression of proteins | |
| ZA202210284B (en) | Anti-trem1 antibodies and related methods | |
| GB201703416D0 (en) | Method for protein expression | |
| GB201818663D0 (en) | Peptides and method | |
| GB2575017B (en) | Alignment Arrangement and Method of Alignment | |
| GB201802757D0 (en) | Analyitical method and means | |
| GB201801920D0 (en) | Polypeptides and methods | |
| HK1218916A1 (zh) | 種固定化蛋白的方法 | |
| GB201704922D0 (en) | Methods of protein stapling |